ACTIVE

PHOENIX Pharma Belgium

Export PDF

Financial year 2026 · Closed on 31/01/2026

Net result3,8 M €+114,8 %over 1 year
Revenue1,3 Md €+7,3 %over 1 year
Equity46,5 M €+8,9 %over 1 year
Workforce496,7 ETP-2,9 %over 1 year

Identity

Source · BCE/KBO

PHOENIX Pharma Belgium is a Public limited company incorporated in 1983. Its registered office is in Woluwe-Saint-Lambert. It employs on average 496,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0425.353.116
Incorporation
28/12/1983
Legal form
Public limited company
Registered office
Avenue Emile Vandervelde 82
1200 Woluwe-Saint-Lambert · BruxellesSee on map
Contributed capital
36 912 565,00 €
Latest accounts
31/01/2026
Average workforce
496,7 ETP
Joint committees (1)
  • 321
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 22 filings

Trend over 8 financial years

20262025202320212020
Income statement
Revenue1,3 Md €1,2 Md €1,1 Md €1 Md €1,1 Md €
EBITDA9,1 M €7 M €3,5 M €-182,5 k €2,4 M €
Operating result5 M €2,6 M €-2,1 M €-32,1 M €-1,2 M €
Net result3,8 M €1,8 M €-2,7 M €-30,7 M €765,2 k €
Balance sheet
Equity46,5 M €42,7 M €18,8 M €19,3 M €33,3 M €
Total assets235,4 M €222,6 M €220,9 M €220,8 M €260,2 M €
Cash56,4 k €829 €217,9 k €304 k €425,8 k €
Debts183,3 M €175,1 M €197,4 M €166,7 M €220,1 M €
Other
Workforce496,7 ETP511,3 ETP560,1 ETP597,3 ETP614,7 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/03/2023

3 active · 8 ended

Last known composition, from the accounts closed on 31/03/2023, more than two years before the latest accounts. The mandates shown may have expired.

Active mandates

Hubert OLIVIER

Director · since 15 septembre 2021 · until 31 octobre 2022

Active
Philippe LACROIX

Managing director · since 15 septembre 2021 · until 18 septembre 2024

Active
Arnaud Berken

Director · since 01 septembre 2020 · until 20 septembre 2023

Active

Ended mandates

Alain CHARLIER

Director · since 20 septembre 2018 · until 15 septembre 2021

Ended
Hubert OLIVIER

Director · since 20 septembre 2018 · until 15 septembre 2021

Ended
Philippe LACROIX

Managing director · since 20 septembre 2018 · until 15 septembre 2021

Ended
CAMBOUNET Jean-Michel

Director · since 01 avril 2018 · until 30 avril 2020

Ended

Other companies at this address

Avenue Emile Vandervelde 82 1200 Woluwe-Saint-Lambert
CompanyCBE no.
SOFARMEX● Active
0654.747.129

Full financial information

Source · NBB
202620252024202320222021
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/02/202501/02/202401/04/202301/04/202201/04/202101/04/2020
Closing of the financial year31/01/202631/01/202531/01/202431/03/202331/03/202231/03/2021
Length of the financial year12 months12 months10 months12 months12 months12 months
Filing date25/06/202607/07/202504/07/202411/10/202307/10/202214/12/2021
General meeting17/06/202618/06/202519/06/202420/09/202321/09/202207/12/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 22 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/01/202617/06/202625/06/2026FrenchPDF
Full model31/01/202518/06/202507/07/2025FrenchPDF
Full model31/01/202419/06/202404/07/2024FrenchPDF
Full model31/03/202320/09/202311/10/2023FrenchPDF
Full model31/03/202221/09/202207/10/2022FrenchPDF
Full model31/03/202107/12/202114/12/2021FrenchPDF
Full model31/03/202016/09/202008/10/2020FrenchPDF
Full model31/03/201918/09/201930/09/2019FrenchPDF
Full model31/03/201918/09/201930/09/2019DutchPDF
Full model31/03/201819/09/201816/10/2018FrenchPDF
Full model31/03/201720/09/201709/10/2017FrenchPDF
Full model31/03/201621/09/201623/09/2016FrenchPDF
Full model31/03/201518/05/201520/05/2015FrenchPDF
Full model31/12/201415/04/201511/05/2015FrenchPDF
Full model31/12/201316/04/201408/05/2014FrenchPDF
Full model31/12/201217/04/201314/05/2013FrenchPDF
Full model31/12/201118/04/201210/05/2012FrenchPDF
Full model31/12/201020/04/201112/05/2011FrenchPDF
Full model31/12/200921/04/201006/05/2010FrenchPDF
Full model31/12/200815/04/200908/05/2009FrenchPDF
Full model31/12/200716/04/200813/05/2008FrenchPDF
Full model31/12/200618/04/200701/06/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2023

3 active · 8 ended

Last known composition, from the accounts closed on 31/03/2023, more than two years before the latest accounts. The mandates shown may have expired.

Active mandates

Hubert OLIVIER

Director · since 15 septembre 2021 · until 31 octobre 2022

Active
Philippe LACROIX

Managing director · since 15 septembre 2021 · until 18 septembre 2024

Active
Arnaud Berken

Director · since 01 septembre 2020 · until 20 septembre 2023

Active

Ended mandates

Alain CHARLIER

Director · since 20 septembre 2018 · until 15 septembre 2021

Ended
Hubert OLIVIER

Director · since 20 septembre 2018 · until 15 septembre 2021

Ended
Philippe LACROIX

Managing director · since 20 septembre 2018 · until 15 septembre 2021

Ended
CAMBOUNET Jean-Michel

Director · since 01 avril 2018 · until 30 avril 2020

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates03/09/2026
    Hernieuwing van het mandaat van één van de bestuurders van de
    PDF
  • Mandates03/09/2026
    Renouvellement du mandat d’un des administrateurs
    PDF
  • Mandates15/07/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/07/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Other25/02/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING
    PDF
  • Mandates25/02/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DENOMINATION
    PDF
  • Mandates22/07/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/07/2024
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2026
    Annual accounts 20263,8 M €↑
  2. 18/06/2025
    nominationForvis Mazars Réviseurs d'Entreprises SRL/Bedrijfsrevisoren BV — commissaris
  3. 18/06/2025
    nominationThomas Verhamme — vertegenwoordiger van de commissaris
  4. 18/06/2025
    nominationForvis Mazars Réviseurs d'Entreprises SRL/Bedrijfsrevisoren BV — commissaire
  5. 18/06/2025
    nominationThomas Verhamme — commissaire (représentant de Forvis Mazars)
  6. 2025
    Annual accounts 20251,8 M €↑
  7. 2025
    Name changePHOENIX Pharma Belgium
  8. 19/06/2024
    reconductionPhilippe Lacroix — bestuurder
  9. 19/06/2024
    nominationJulie Delforge — commissaris
  10. 19/06/2024
    reconductionPhilippe Lacroix — administrateur
  11. 19/06/2024
    nominationJulie Delforge — commissaire aux comptes
  12. 30/01/2024
    augmentation_capital
  13. 20/09/2023
    reconductionArnaud Berken — bestuurder
  14. 20/09/2023
    reconductionArnaud Berken — administrateur
  15. 2023
    Annual accounts 2023-2,7 M €↑
  16. 2021
    Annual accounts 2021-30,7 M €↓
  17. 2020
    Annual accounts 2020765,2 k €↓
  18. 2019
    Annual accounts 20191,8 M €↑
  19. 2018
    Annual accounts 2018-8,7 M €↓
  20. 2018
    Name changePharma Belgium Belmedis
  21. 2017
    Annual accounts 2017-382,1 k €
  22. 2017
    Name changePHARMA BELGIUM
  23. 28/12/1983
    IncorporationPublic limited company